https://www.prnewswire.com/news-releases/vividion-therapeutics-to-present-data-on-novel-covalent-e3-ligase-engager-supporting-broad-targeted-protein-degradation-at-2020-aacr-annual-meeting-301059997.html
Vividion Therapeutics to Present Data on Novel Covalent E3 Ligase Engager Supporting Broad Targeted...
/PRNewswire/ -- Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally...
https://www.fiercebiotech.com/biotech/bayer-bets-1-5b-vividion-will-help-it-target-undruggable-and-make-1-1-3
Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3 | Fierce Biotech
Aug 5, 2021 - Sometimes, it takes $1.5 billion to make "one plus one equal three."